ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,243.82
0.70%
Dow Jones
39,935.07
0.00%
Gold vs US Dollar
2,374.15
0.42%
Brent Oil
81.165
-0.45%
Bitcoin
67,317.96
2.32%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
26/07/202412:50UK RegulatoryGlobal Opportunities Trust Plc - Net Asset Value(s)LSE:GOTGlobal Opportunities Trust Plc
26/07/202412:49Alliance NewsAlliance NewsSoftware Circle buys Link Maker in GBP4.5 million dealLSE:SFTSoftware Circle Plc
26/07/202412:46Alliance NewsAlliance NewseEnergy reports 44% decrease in core revenue for first halfLSE:EAASEenergy Group Plc
26/07/202412:45UK RegulatoryGENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary CholangitisTG:XUPGenfit
26/07/202412:45UK RegulatoryGENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire PrimitiveEU:GNFTGenfit
26/07/202412:45UK RegulatoryGENFIT : Avis positif du Comité des médicaments à usage humain (CHMP) pour l’Iqirvo® (élafibranor) d’Ipsen dans la Cholangite Biliaire PrimitiveTG:XUPGenfit
26/07/202412:45UK RegulatoryGENFIT: Positive Opinion from EMA Committee for Ipsen’s Iqirvo® (elafibranor) in Primary Biliary CholangitisEU:GNFTGenfit
26/07/202412:44UK RegulatoryIssue of Equity - DRISLSE:DDV1Downing One Vct Plc
26/07/202412:44UK RegulatoryIssue of Equity - DRISLSE:TV1Thames Ventures Vct 1 Plc
26/07/202412:41UK RegulatoryStrategic Equity Capital Plc - Net Asset Value(s)LSE:SECStrategic Equity Capital Plc
26/07/202412:34UK RegulatoryStellar Asset Management Ltd - Form 8.3 - Equals Group PlcLSE:EQLSEquals Group Plc
26/07/202412:33Alliance NewsAlliance NewsMacquarie buys National Grid's remaining stake in National GasTG:4M4Macquarie Group Ltd
26/07/202412:33Alliance NewsAlliance NewsMacquarie buys National Grid's remaining stake in National GasLSE:NG.National Grid Plc
26/07/202412:32UK RegulatoryInvesco Ltd: Form 8.3 - Quanex Building Products Corporation
26/07/202412:31Alliance NewsAlliance NewsCOMMODITIES MARKET: Oil still strong after US GDP; cautious gold ease
26/07/202412:30UK RegulatoryPremier Miton Global Renewables Trust Plc - Net Asset Value(s)LSE:PMGRPremier Miton Global Renewables Trust Plc
26/07/202412:30UK RegulatoryPremier Miton Global Renewables Trust Plc - Net Asset Value(s)LSE:PMGZPmgr Secs 2025
26/07/202412:30PR Newswire (US)Auto Industry Sees Significant Shifts in First Half of 2024; Nearly Unrecognizable From Five Years Ago, According to Cars Commerce Industry Insights ReportNYSE:CARSCars com Inc
26/07/202412:28UK RegulatoryInvesco Ltd: Form 8.3 - Bellway PLC
26/07/202412:26UK RegulatoryDatang Intnl Pwr Gen - Inside Information AnnouncementLSE:DATDatang International Power Generation Company Ld
26/07/202412:22UK RegulatoryThe Diverse Income Trust Plc - Net Asset Value(s)LSE:DIVIDiverse Income Trust (the) Plc
26/07/202412:20UK RegulatoryUpdate on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European UnionBIT:1BIIBBiogen Inc
26/07/202412:20UK RegulatoryUpdate on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European UnionLSE:0R1BBiogen Inc
26/07/202412:20UK RegulatoryUpdate on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European UnionXE:IDPBiogen Inc
26/07/202412:20UK RegulatoryUpdate on Regulatory Review of Lecanemab for Early Alzheimer’s Disease in the European UnionTG:IDPBiogen Inc
26/07/202412:18UK RegulatoryBlackRock Frontiers Investment Trust Plc - Net Asset Value(s)LSE:BRFIBlackrock Frontiers Investment Trust Plc
26/07/202412:17UK RegulatoryInvesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
26/07/202412:17UK RegulatoryBlackRock Income and Growth Investment Trust Plc - Net Asset Value(s)LSE:BRIGBlackrock Income And Growth Investment Trust Plc
26/07/202412:17UK RegulatoryBlackRock Smaller Companies Trust Plc - Net Asset Value(s)LSE:BRSCBlackrock Smaller Co Trust Plc
26/07/202412:16UK RegulatoryBlackRock Sustainable American Income Trust Plc - Net Asset Value(s)LSE:BRSABlackrock Sustainable American Income Trust Plc

Your Recent History

LSE
LLOY
Lloyds Banking
LSE
PANR
Pantheon Resources
LSE
GDR
Genedrive
LSE
PPP
Pennpetro Energy
LSE
UKOG
Uk Oil & Gas
LSE
SOLG
Solgold
LSE
OCDO
Ocado
LSE
BIRD
Blackbird
LSE
SBTX
Skinbiotherapeutics
LSE
POS
Plexus
LSE
SCLP
Scancell
LSE
AAZ
Anglo Asian Mining
LSE
VAST
Vast Resources
LSE
EME
Empyrean Energy
LSE
NWG
Natwest
LSE
INSP
Inspirit Energy
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved